Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
36 hedge funds and large institutions have $65.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 1 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 1
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
50% more funds holding
Funds holding: 24 → 36 (+12)
9% more capital invested
Capital invested by funds: $60M → $65.3M (+$5.31M)
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $273K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIP
ARS Investment Partners
New York
|
+$1.23M |
| 2 |
RA
Royce & Associates
New York
|
+$1.12M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$645K |
| 4 |
Renaissance Technologies
New York
|
+$590K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$569K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.55M |
| 2 |
Jane Street
New York
|
-$40K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$4.89K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$4.85K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.36K |
CORV Hedge Fund Activity: Q3 2018 in Review
36 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2018, worth a combined $65.3M — up 8.9% from $60M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CORV positions and 1 closed out — a net gain of 12 holders — while 10 added to existing stakes and 4 trimmed.
The largest buyer was ARS Investment Partners, opening a new position worth an estimated $1.23M. The largest seller was Stonepine Capital Management, cutting an estimated $4.55M.
- 36 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2018, up from 24 in Q2 2018.
- Funds reported $65.3M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2018, up 8.9% quarter-over-quarter.
- 13 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2018 and 1 closed out, a net change of +12 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2018 was ARS Investment Partners, an estimated $1.23M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2018 was Stonepine Capital Management, an estimated $4.55M sold.
Based on aggregated 13F filings for Q3 2018.